US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

25.00

-0.5000-1.96%

Post-market: 25.220.2188+0.88%19:56 EDT

Volume:204.05K

Turnover:5.09M

Market Cap:171.35M

PE:-0.07

High:25.56

Open:25.16

Low:24.59

Close:25.50

52wk High:65.80

52wk Low:2.62

Shares:6.85M

Float Shares:3.18M

Volume Ratio:0.45

T/O Rate:6.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-342.6591

EPS(LYR):-34.0333

ROE:-125.43%

ROA:-121.29%

PB:-0.11

PE(LYR):-0.73

Loading ...

Overview Company News Filings

Vor Biopharma Is Maintained at Buy by HC Wainwright & Co.

BRIEF-Vor Biopharma Says 100% Patients On Telitacicept Achieve ≥2-Point MG-ADL Improvement

Vor Bio says telitacicept shows sustained efficacy in China Phase 3 study

Vor Biopharma Reports Telitacicept Achieves Sustained Efficacy in Phase 3 Myasthenia Gravis Trial

Vor Biopharma Inc - 100% Patients on Telitacicept Achieve ≥2-Point Mg-Adl Improvement

THOMSON REUTERS

Vor Biopharma Inc - Telitacicept Shows Favorable Profile Compared to Placebo

THOMSON REUTERS

Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data

THOMSON REUTERS

Vor Biopharma Inc - No Injection Site Reactions in Telitacicept Patients

THOMSON REUTERS

Corrected-Vor Biopharma Inc. : H.c. Wainwright Raises Target Price to $55(Not $52) From $3 to Reflect 1-for-20 Reverse Stock Split (Clarifies PT Is Split-Adjusted)

THOMSON REUTERS

Vor Biopharma Unveils Promising Phase 3 Trial Results

Peter Kolchinsky, Director, Reports Disposal of Vor Biopharma Inc. Common Shares

Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma

RA Capital Management Reports Disposal of Vor Biopharma Common Shares

Major Shareholder Offloads Thousands of Vor Biopharma Shares!

Reprogrammed Interchange LLC Reports Disposal of Vor Biopharma Inc. Common Shares

Major Vor Biopharma Stock Sales by Key Shareholders!

RA Capital Management Reports Sale of Vor Biopharma Inc. Common Shares

Vor Biopharma Announces Positive Phase 3 Results for Telitacicept in IgA Nephropathy; Data to Be Presented at ASN Kidney Week 2025

Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 Iga Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025

THOMSON REUTERS

Vor Biopharma Announces Positive Phase 3 Trial Results for Telitacicept in Lupus, Published in NEJM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VOR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VOR\",,,,,undefined,":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":25,"timestamp":1761854400000,"preClose":25.5,"halted":0,"volume":204049,"hourTrading":{"tag":"盘后","latestPrice":25.2188,"preClose":25,"latestTime":"19:56 EDT","volume":320,"amount":7973.34,"timestamp":1761868607927},"delay":0,"floatShares":3175130,"shares":6853907,"eps":-342.65912,"marketStatus":"Closed","change":-0.5,"latestTime":"10-30 16:00:00 EDT","open":25.16,"high":25.56,"low":24.59,"amount":5093421.758142,"amplitude":0.038039,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-342.65912,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761897600000},"marketStatusCode":5,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":25.5,"preHourTrading":{"tag":"盘前","latestPrice":25.01,"preClose":25.5,"latestTime":"09:22 EDT","volume":1924,"amount":48526.764363999995,"timestamp":1761830561683},"postHourTrading":{"tag":"盘后","latestPrice":25.2188,"preClose":25,"latestTime":"19:56 EDT","volume":320,"amount":7973.34,"timestamp":1761868607927},"volumeRatio":0.450709,"impliedVol":1.3167,"impliedVolPercentile":0.5339},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VOR\",,,,,undefined,":{"symbol":"VOR","floatShares":3175130,"roa":"-121.29%","roe":"-125.43%","lyrEps":-34.0333,"volumeRatio":0.450709,"shares":6853907,"dividePrice":0,"high":25.56,"amplitude":0.038039,"preClose":25.5,"low":24.59,"week52Low":2.622,"pbRate":"-0.11","week52High":65.8,"institutionHeld":0,"latestPrice":25,"eps":-342.65912,"divideRate":0,"volume":204049,"delay":0,"ttmEps":-342.65912,"open":25.16,"prevYearClose":22.2,"prevWeekClose":27.19,"prevMonthClose":48.72,"prevQuarterClose":48.72,"fiveDayClose":27.76,"twentyDayClose":36.68,"sixtyDayClose":41.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-19","symbol":"VOR","defaultRemindTime":1758288600000,"type":"split","dateTimestamp":1758254400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2025-08-12","symbol":"VOR","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-2.18},{"market":"US","date":"2025-05-14","symbol":"VOR","fiscalQuarterEnding":"2025/03","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-03-20","symbol":"VOR","fiscalQuarterEnding":"2024/12","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2024-11-07","symbol":"VOR","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.2,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1760500800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VOR","date":"2025-10-29","current":-0.072142,"percent":0.999139,"low":-63.593381,"twenty":-6.372563,"median":-2.0668,"eighty":-0.740311,"high":-0.109124,"avg":-5.238508,"sd":9.375865,"marketCap":184541445},"quantilePoints":[{"date":"2021-02-05","current":-41.152184,"twenty":-32.59253,"median":-19.753048,"eighty":-19.753048,"marketCap":1299051000},{"date":"2021-02-12","current":-57.361041,"twenty":-51.03698,"median":-47.767415,"eighty":-28.312702,"marketCap":1810715990},{"date":"2021-02-19","current":-57.51391,"twenty":-57.483336,"median":-50.934676,"eighty":-42.322003,"marketCap":1815541596},{"date":"2021-02-26","current":-52.869053,"twenty":-58.040719,"median":-52.869053,"eighty":-47.307734,"marketCap":1668917403},{"date":"2021-03-05","current":-39.24022,"twenty":-57.483336,"median":-51.263931,"eighty":-42.322003,"marketCap":1238696035},{"date":"2021-03-12","current":-52.210542,"twenty":-57.177599,"median":-50.540745,"eighty":-41.75991,"marketCap":1648130175},{"date":"2021-03-19","current":-47.742072,"twenty":-56.018148,"median":-49.307844,"eighty":-44.282535,"marketCap":1507073989},{"date":"2021-03-26","current":-31.338978,"twenty":-54.29426,"median":-48.533548,"eighty":-41.75991,"marketCap":1358137301},{"date":"2021-04-01","current":-33.223772,"twenty":-54.209594,"median":-47.742072,"eighty":-36.924821,"marketCap":1439818604},{"date":"2021-04-09","current":-27.432315,"twenty":-52.869053,"median":-47.0483,"eighty":-33.223772,"marketCap":1188834237},{"date":"2021-04-16","current":-25.787404,"twenty":-52.210542,"median":-45.519596,"eighty":-31.279008,"marketCap":1117548736},{"date":"2021-04-23","current":-25.487551,"twenty":-51.446198,"median":-44.420118,"eighty":-27.526555,"marketCap":1104553983},{"date":"2021-04-30","current":-24.142493,"twenty":-51.399162,"median":-39.628272,"eighty":-25.487551,"marketCap":1046263235},{"date":"2021-05-07","current":-18.508849,"twenty":-51.081665,"median":-36.665546,"eighty":-24.870709,"marketCap":910838957},{"date":"2021-05-14","current":-14.713516,"twenty":-50.540745,"median":-33.463655,"eighty":-24.468049,"marketCap":724066843},{"date":"2021-05-21","current":-16.282958,"twenty":-50.423154,"median":-32.294226,"eighty":-23.020184,"marketCap":801300640},{"date":"2021-05-28","current":-15.920779,"twenty":-50.082139,"median":-31.279008,"eighty":-18.508849,"marketCap":783477456},{"date":"2021-06-04","current":-15.407692,"twenty":-49.329555,"median":-28.888746,"eighty":-16.96657,"marketCap":758227945},{"date":"2021-06-11","current":-16.049051,"twenty":-48.65512,"median":-27.479435,"eighty":-16.240704,"marketCap":789789833},{"date":"2021-06-18","current":-15.73969,"twenty":-48.079106,"median":-25.787404,"eighty":-16.036978,"marketCap":774565864},{"date":"2021-06-25","current":-16.071687,"twenty":-47.786757,"median":-25.431863,"eighty":-15.908706,"marketCap":790903782},{"date":"2021-07-02","current":-15.377511,"twenty":-47.22467,"median":-24.870709,"eighty":-15.700454,"marketCap":756742680},{"date":"2021-07-09","current":-14.472064,"twenty":-47.09532,"median":-24.759335,"eighty":-15.462019,"marketCap":712184720},{"date":"2021-07-16","current":-11.838721,"twenty":-47.038897,"median":-24.305271,"eighty":-15.270366,"marketCap":582595321},{"date":"2021-07-23","current":-9.809011,"twenty":-46.92365,"median":-23.34574,"eighty":-15.074186,"marketCap":482711229},{"date":"2021-07-30","current":-9.446832,"twenty":-46.060516,"median":-20.761207,"eighty":-14.900642,"marketCap":464888045},{"date":"2021-08-06","current":-10.18628,"twenty":-45.512541,"median":-18.508849,"eighty":-14.463009,"marketCap":501277045},{"date":"2021-08-13","current":-8.821219,"twenty":-44.992787,"median":-17.407221,"eighty":-14.194393,"marketCap":525224177},{"date":"2021-08-20","current":-8.27847,"twenty":-44.374257,"median":-16.80359,"eighty":-12.368408,"marketCap":492908404},{"date":"2021-08-27","current":-9.588552,"twenty":-42.367636,"median":-16.339548,"eighty":-11.505215,"marketCap":570911994},{"date":"2021-09-03","current":-9.688368,"twenty":-40.237837,"median":-16.086778,"eighty":-10.349261,"marketCap":576855125},{"date":"2021-09-10","current":-9.644699,"twenty":-39.473051,"median":-16.071687,"eighty":-10.093885,"marketCap":574255005},{"date":"2021-09-17","current":-9.582314,"twenty":-38.31406,"median":-15.954733,"eighty":-9.768221,"marketCap":570540549},{"date":"2021-09-24","current":-8.471863,"twenty":-36.717401,"median":-15.75478,"eighty":-9.695854,"marketCap":504423219},{"date":"2021-10-01","current":-9.632222,"twenty":-35.249785,"median":-15.641599,"eighty":-9.653079,"marketCap":573512114},{"date":"2021-10-08","current":-8.852411,"twenty":-33.494497,"median":-15.498237,"eighty":-9.595245,"marketCap":527081405},{"date":"2021-10-15","current":-9.644699,"twenty":-33.367702,"median":-15.358648,"eighty":-9.556112,"marketCap":574255005},{"date":"2021-10-22","current":-10.405794,"twenty":-32.980462,"median":-15.188876,"eighty":-9.556112,"marketCap":619571377},{"date":"2021-10-29","current":-9.813138,"twenty":-32.35848,"median":-15.12474,"eighty":-9.567342,"marketCap":584284038},{"date":"2021-11-05","current":-11.191843,"twenty":-31.719364,"median":-14.962514,"eighty":-9.582314,"marketCap":666373531},{"date":"2021-11-12","current":-9.981733,"twenty":-31.31499,"median":-14.894606,"eighty":-9.567342,"marketCap":661888696},{"date":"2021-11-19","current":-7.636728,"twenty":-30.830084,"median":-14.713516,"eighty":-9.523672,"marketCap":506391464},{"date":"2021-11-26","current":-6.748214,"twenty":-29.903108,"median":-14.449427,"eighty":-9.416101,"marketCap":447474048},{"date":"2021-12-03","current":-7.102495,"twenty":-28.883606,"median":-14.343792,"eighty":-9.267894,"marketCap":470966435},{"date":"2021-12-10","current":-7.507388,"twenty":-28.595747,"median":-13.747706,"eighty":-9.203014,"marketCap":497814878},{"date":"2021-12-17","current":-7.496141,"twenty":-27.507707,"median":-12.2839,"eighty":-9.08074,"marketCap":497069088},{"date":"2021-12-23","current":-7.400541,"twenty":-27.432315,"median":-11.751949,"eighty":-8.871126,"marketCap":490729872},{"date":"2021-12-31","current":-6.53452,"twenty":-26.986818,"median":-11.287908,"eighty":-8.777549,"marketCap":433304036},{"date":"2022-01-07","current":-5.949675,"twenty":-25.787404,"median":-11.210559,"eighty":-8.598349,"marketCap":394522952},{"date":"2022-01-14","current":-5.128642,"twenty":-25.487551,"median":-11.085789,"eighty":-8.471863,"marketCap":340080276},{"date":"2022-01-21","current":-4.72375,"twenty":-25.453281,"median":-10.631459,"eighty":-8.259755,"marketCap":313231833},{"date":"2022-01-28","current":-4.358221,"twenty":-25.424153,"median":-10.337188,"eighty":-8.042153,"marketCap":288993656},{"date":"2022-02-04","current":-4.459445,"twenty":-25.055762,"median":-10.231116,"eighty":-7.636564,"marketCap":295705766},{"date":"2022-02-11","current":-4.83622,"twenty":-24.889557,"median":-10.13442,"eighty":-7.505139,"marketCap":320689734},{"date":"2022-02-18","current":-5.25236,"twenty":-24.822732,"median":-10.111073,"eighty":-7.280198,"marketCap":348283967},{"date":"2022-02-25","current":-4.841843,"twenty":-24.779896,"median":-9.981733,"eighty":-7.051883,"marketCap":321062629},{"date":"2022-03-04","current":-4.352598,"twenty":-24.671949,"median":-9.912954,"eighty":-6.914669,"marketCap":288620760},{"date":"2022-03-11","current":-4.785608,"twenty":-24.526306,"median":-9.856807,"eighty":-6.824693,"marketCap":317333679},{"date":"2022-03-18","current":-4.570492,"twenty":-24.272715,"median":-9.795478,"eighty":-6.659362,"marketCap":314902308},{"date":"2022-03-25","current":-3.68904,"twenty":-23.705564,"median":-9.769468,"eighty":-6.485033,"marketCap":254171148},{"date":"2022-04-01","current":-3.438751,"twenty":-23.373155,"median":-9.741473,"eighty":-6.040776,"marketCap":236926498},{"date":"2022-04-08","current":-3.242873,"twenty":-23.150406,"median":-9.725799,"eighty":-5.378326,"marketCap":223430685},{"date":"2022-04-14","current":-3.183021,"twenty":-22.519857,"median":-9.688368,"eighty":-5.161259,"marketCap":219306964},{"date":"2022-04-22","current":-3.057877,"twenty":-20.962839,"median":-9.644699,"eighty":-5.002676,"marketCap":210684639},{"date":"2022-04-29","current":-3.119646,"twenty":-19.753048,"median":-9.605285,"eighty":-4.884582,"marketCap":214940516},{"date":"2022-05-06","current":-2.760315,"twenty":-19.255368,"median":-9.582314,"eighty":-4.841843,"marketCap":190182970},{"date":"2022-05-13","current":-2.036439,"twenty":-18.240233,"median":-9.538644,"eighty":-4.787858,"marketCap":158665041},{"date":"2022-05-20","current":-2.166732,"twenty":-17.8192,"median":-9.435918,"eighty":-4.694507,"marketCap":168816595},{"date":"2022-05-27","current":-2.036439,"twenty":-17.484184,"median":-9.401398,"eighty":-4.616903,"marketCap":158665041},{"date":"2022-06-03","current":-2.19086,"twenty":-16.984679,"median":-9.357728,"eighty":-4.557434,"marketCap":170696513},{"date":"2022-06-10","current":-2.668603,"twenty":-16.827736,"median":-9.244271,"eighty":-4.459445,"marketCap":207918881},{"date":"2022-06-17","current":-2.277723,"twenty":-16.791517,"median":-9.201766,"eighty":-4.388588,"marketCap":177464216},{"date":"2022-06-24","current":-2.89541,"twenty":-16.743227,"median":-9.164335,"eighty":-4.279492,"marketCap":225590106},{"date":"2022-07-01","current":-2.321154,"twenty":-16.381048,"median":-9.039504,"eighty":-4.155775,"marketCap":180848068},{"date":"2022-07-08","current":-2.663778,"twenty":-16.314649,"median":-8.892961,"eighty":-3.985034,"marketCap":207542897},{"date":"2022-07-15","current":-2.57209,"twenty":-16.285976,"median":-8.821219,"eighty":-3.460515,"marketCap":200399210},{"date":"2022-07-22","current":-2.297026,"twenty":-16.126014,"median":-8.765072,"eighty":-3.286401,"marketCap":178968150},{"date":"2022-07-29","current":-2.22464,"twenty":-16.074705,"median":-8.627826,"eighty":-3.236739,"marketCap":173328398},{"date":"2022-08-05","current":-2.412842,"twenty":-16.071687,"median":-8.574798,"eighty":-3.155816,"marketCap":187991755},{"date":"2022-08-12","current":-2.530776,"twenty":-16.053578,"median":-8.471863,"eighty":-3.105113,"marketCap":205504052},{"date":"2022-08-19","current":-2.310505,"twenty":-16.000761,"median":-8.272232,"eighty":-3.029952,"marketCap":187617588},{"date":"2022-08-26","current":-2.291758,"twenty":-15.934361,"median":-8.178655,"eighty":-2.900578,"marketCap":186095336},{"date":"2022-09-02","current":-2.460476,"twenty":-15.872489,"median":-7.987125,"eighty":-2.780722,"marketCap":199795606},{"date":"2022-09-09","current":-2.41361,"twenty":-15.797034,"median":-7.780128,"eighty":-2.680185,"marketCap":195989975},{"date":"2022-09-16","current":-2.207399,"twenty":-15.745726,"median":-7.635906,"eighty":-2.589462,"marketCap":179245201},{"date":"2022-09-23","current":-2.043367,"twenty":-15.73969,"median":-7.515823,"eighty":-2.534567,"marketCap":165925494},{"date":"2022-09-30","current":-1.865275,"twenty":-15.621981,"median":-7.400541,"eighty":-2.509356,"marketCap":151464097},{"date":"2022-10-07","current":-1.841842,"twenty":-15.520873,"median":-7.259953,"eighty":-2.492366,"marketCap":149561282},{"date":"2022-10-14","current":-1.785603,"twenty":-15.501255,"median":-7.074377,"eighty":-2.468515,"marketCap":144994525},{"date":"2022-10-21","current":-1.930888,"twenty":-15.44391,"median":-7.004084,"eighty":-2.449435,"marketCap":156791980},{"date":"2022-10-28","current":-2.263638,"twenty":-15.389583,"median":-6.877554,"eighty":-2.41894,"marketCap":183811957},{"date":"2022-11-04","current":-2.010561,"twenty":-15.354875,"median":-6.849437,"eighty":-2.408819,"marketCap":163261552},{"date":"2022-11-11","current":-1.869875,"twenty":-15.330729,"median":-6.776331,"eighty":-2.394864,"marketCap":161624540},{"date":"2022-11-18","current":-1.910136,"twenty":-15.243203,"median":-6.652614,"eighty":-2.375365,"marketCap":165104494},{"date":"2022-11-25","current":-1.96829,"twenty":-15.179822,"median":-6.53452,"eighty":-2.352038,"marketCap":170131095},{"date":"2022-12-02","current":-2.214326,"twenty":-15.154167,"median":-6.478285,"eighty":-2.326439,"marketCap":191397482},{"date":"2022-12-09","current":-4.917676,"twenty":-15.127004,"median":-6.233662,"eighty":-2.322518,"marketCap":425064231},{"date":"2022-12-16","current":-5.369774,"twenty":-15.074186,"median":-5.949675,"eighty":-2.326439,"marketCap":464141781},{"date":"2022-12-23","current":-5.324203,"twenty":-14.994205,"median":-5.591546,"eighty":-2.329251,"marketCap":460202812},{"date":"2022-12-30","current":-5.050777,"twenty":-14.956478,"median":-5.454064,"eighty":-2.330188,"marketCap":436569002},{"date":"2023-01-06","current":-4.876089,"twenty":-14.932333,"median":-5.403952,"eighty":-2.333938,"marketCap":421469623},{"date":"2023-01-13","current":-4.458355,"twenty":-14.924787,"median":-5.324203,"eighty":-2.350108,"marketCap":385362412},{"date":"2023-01-20","current":-4.253286,"twenty":-14.876497,"median":-5.263607,"eighty":-2.353969,"marketCap":367637054},{"date":"2023-01-27","current":-3.93429,"twenty":-14.761806,"median":-5.217405,"eighty":-2.360632,"marketCap":340064275},{"date":"2023-02-03","current":-4.16974,"twenty":-14.718043,"median":-5.134266,"eighty":-2.3718,"marketCap":360415612},{"date":"2023-02-10","current":-4.207715,"twenty":-14.520354,"median":-5.098583,"eighty":-2.375741,"marketCap":363698085},{"date":"2023-02-17","current":-4.443165,"twenty":-14.453954,"median":-5.049913,"eighty":-2.382334,"marketCap":384049422},{"date":"2023-02-24","current":-4.488736,"twenty":-14.449427,"median":-4.971184,"eighty":-2.387661,"marketCap":387988391},{"date":"2023-03-03","current":-3.972266,"twenty":-14.426791,"median":-4.945728,"eighty":-2.392989,"marketCap":343346749},{"date":"2023-03-10","current":-3.554532,"twenty":-14.33021,"median":-4.914949,"eighty":-2.394864,"marketCap":307239538},{"date":"2023-03-17","current":-3.903909,"twenty":-14.153648,"median":-4.870321,"eighty":-2.396965,"marketCap":337438296},{"date":"2023-03-24","current":-4.237821,"twenty":-13.877487,"median":-4.85309,"eighty":-2.398365,"marketCap":390277849},{"date":"2023-03-31","current":-3.877462,"twenty":-13.716015,"median":-4.841843,"eighty":-2.401888,"marketCap":357090957},{"date":"2023-04-06","current":-3.675661,"twenty":-13.29951,"median":-4.819349,"eighty":-2.407291,"marketCap":338506298},{"date":"2023-04-14","current":-3.560346,"twenty":-12.368408,"median":-4.785608,"eighty":-2.412261,"marketCap":327886492},{"date":"2023-04-21","current":-3.183431,"twenty":-11.852303,"median":-4.763624,"eighty":-2.412842,"marketCap":293174853},{"date":"2023-04-28","current":-3.197967,"twenty":-11.769303,"median":-4.718126,"eighty":-2.413149,"marketCap":294513551},{"date":"2023-05-05","current":-2.798221,"twenty":-11.662159,"median":-4.655829,"eighty":-2.415387,"marketCap":257699357},{"date":"2023-05-12","current":-3.118018,"twenty":-11.577651,"median":-4.633408,"eighty":-2.424423,"marketCap":287150712},{"date":"2023-05-19","current":-2.97747,"twenty":-11.278677,"median":-4.616903,"eighty":-2.43311,"marketCap":291166806},{"date":"2023-05-26","current":-3.211242,"twenty":-11.239256,"median":-4.604159,"eighty":-2.438859,"marketCap":314027392},{"date":"2023-06-02","current":-3.245477,"twenty":-11.229274,"median":-4.56233,"eighty":-2.446417,"marketCap":317375232},{"date":"2023-06-09","current":-3.64945,"twenty":-11.191843,"median":-4.510056,"eighty":-2.451447,"marketCap":356879744},{"date":"2023-06-16","current":-3.327641,"twenty":-11.137,"median":-4.47409,"eighty":-2.460476,"marketCap":325410048},{"date":"2023-06-22","current":-3.266018,"twenty":-11.106273,"median":-4.459445,"eighty":-2.46085,"marketCap":319383936},{"date":"2023-06-30","current":-2.238969,"twenty":-10.916102,"median":-4.443165,"eighty":-2.448429,"marketCap":218948736},{"date":"2023-07-07","current":-1.882925,"twenty":-10.655549,"median":-4.42038,"eighty":-2.425499,"marketCap":184131200},{"date":"2023-07-14","current":-2.033559,"twenty":-10.586326,"median":-4.391962,"eighty":-2.412996,"marketCap":198861696},{"date":"2023-07-21","current":-2.25951,"twenty":-10.404145,"median":-4.374809,"eighty":-2.399539,"marketCap":220957440},{"date":"2023-07-28","current":-1.924007,"twenty":-10.373406,"median":-4.348513,"eighty":-2.391114,"marketCap":188148608},{"date":"2023-08-04","current":-1.978783,"twenty":-10.268931,"median":-4.283667,"eighty":-2.364493,"marketCap":193505152},{"date":"2023-08-11","current":-1.635797,"twenty":-10.236107,"median":-4.275362,"eighty":-2.330188,"marketCap":173574407},{"date":"2023-08-18","current":-1.858571,"twenty":-10.222149,"median":-4.253286,"eighty":-2.317293,"marketCap":197212945},{"date":"2023-08-25","current":-1.756731,"twenty":-10.176532,"median":-4.234161,"eighty":-2.306755,"marketCap":186406756},{"date":"2023-09-01","current":-1.591242,"twenty":-10.136291,"median":-4.215311,"eighty":-2.292155,"marketCap":168846700},{"date":"2023-09-08","current":-1.623067,"twenty":-10.131301,"median":-4.189617,"eighty":-2.277723,"marketCap":172223634},{"date":"2023-09-15","current":-1.616702,"twenty":-10.125062,"median":-4.177335,"eighty":-2.254265,"marketCap":171548247},{"date":"2023-09-22","current":-1.387563,"twenty":-10.111073,"median":-4.155775,"eighty":-2.214326,"marketCap":147234322},{"date":"2023-09-29","current":-1.349373,"twenty":-10.0731,"median":-4.145444,"eighty":-2.19086,"marketCap":143182001},{"date":"2023-10-06","current":-1.279359,"twenty":-9.981733,"median":-4.124169,"eighty":-2.170499,"marketCap":135752746},{"date":"2023-10-12","current":-1.603972,"twenty":-9.971627,"median":-4.108978,"eighty":-2.155846,"marketCap":170197473},{"date":"2023-10-20","current":-1.400293,"twenty":-9.939155,"median":-4.095453,"eighty":-2.124547,"marketCap":148585096},{"date":"2023-10-27","current":-1.368468,"twenty":-9.924183,"median":-4.093788,"eighty":-2.122716,"marketCap":145208162},{"date":"2023-11-03","current":-1.113869,"twenty":-9.894238,"median":-4.061219,"eighty":-2.118353,"marketCap":118192690},{"date":"2023-11-10","current":-1.091822,"twenty":-9.888,"median":-4.048217,"eighty":-2.076173,"marketCap":126118577},{"date":"2023-11-17","current":-1.033122,"twenty":-9.856807,"median":-4.010242,"eighty":-2.065393,"marketCap":119338009},{"date":"2023-11-24","current":-1.080082,"twenty":-9.821872,"median":-3.979861,"eighty":-2.057354,"marketCap":124762464},{"date":"2023-12-01","current":-1.085952,"twenty":-9.809836,"median":-3.96467,"eighty":-2.039613,"marketCap":125440520},{"date":"2023-12-08","current":-1.279663,"twenty":-9.787358,"median":-3.945515,"eighty":-2.033559,"marketCap":147816397},{"date":"2023-12-15","current":-1.414673,"twenty":-9.776955,"median":-3.877462,"eighty":-2.026712,"marketCap":163411705},{"date":"2023-12-22","current":-1.262053,"twenty":-9.770716,"median":-3.862135,"eighty":-2.012531,"marketCap":145782227},{"date":"2023-12-29","current":-1.526203,"twenty":-9.766973,"median":-3.827958,"eighty":-1.998964,"marketCap":176294786},{"date":"2024-01-05","current":-1.179872,"twenty":-9.76323,"median":-3.801786,"eighty":-1.992477,"marketCap":136289430},{"date":"2024-01-12","current":-1.672954,"twenty":-9.748648,"median":-3.774792,"eighty":-1.978783,"marketCap":193246207},{"date":"2024-01-19","current":-1.449893,"twenty":-9.737168,"median":-3.711697,"eighty":-1.958855,"marketCap":167480046},{"date":"2024-01-26","current":-1.397063,"twenty":-9.727499,"median":-3.682351,"eighty":-1.944868,"marketCap":161377535},{"date":"2024-02-02","current":-1.379453,"twenty":-9.725799,"median":-3.64945,"eighty":-1.932503,"marketCap":159343364},{"date":"2024-02-09","current":-1.350103,"twenty":-9.710827,"median":-3.616249,"eighty":-1.925763,"marketCap":155953080},{"date":"2024-02-16","current":-1.244443,"twenty":-9.692111,"median":-3.560346,"eighty":-1.912142,"marketCap":143748056},{"date":"2024-02-23","current":-1.162262,"twenty":-9.674736,"median":-3.533051,"eighty":-1.893395,"marketCap":134255260},{"date":"2024-03-01","current":-1.350103,"twenty":-9.653079,"median":-3.49871,"eighty":-1.882925,"marketCap":155953080},{"date":"2024-03-08","current":-1.297273,"twenty":-9.644699,"median":-3.471428,"eighty":-1.87331,"marketCap":149850568},{"date":"2024-03-15","current":-1.083017,"twenty":-9.637213,"median":-3.452354,"eighty":-1.865139,"marketCap":125101492},{"date":"2024-03-22","current":-1.133611,"twenty":-9.61606,"median":-3.430546,"eighty":-1.854424,"marketCap":133610791},{"date":"2024-03-28","current":-1.278204,"twenty":-9.598592,"median":-3.416987,"eighty":-1.836603,"marketCap":150652983},{"date":"2024-04-05","current":-1.203016,"twenty":-9.586057,"median":-3.385841,"eighty":-1.816534,"marketCap":141791043},{"date":"2024-04-12","current":-1.180694,"twenty":-9.582314,"median":-3.368723,"eighty":-1.800971,"marketCap":139160172},{"date":"2024-04-19","current":-0.972336,"twenty":-9.572332,"median":-3.345545,"eighty":-1.781121,"marketCap":114602495},{"date":"2024-04-26","current":-0.983912,"twenty":-9.549874,"median":-3.320794,"eighty":-1.714723,"marketCap":115966810},{"date":"2024-05-03","current":-1.018638,"twenty":-9.528662,"median":-3.283056,"eighty":-1.675913,"marketCap":120059756},{"date":"2024-05-10","current":-1.027579,"twenty":-9.486947,"median":-3.259196,"eighty":-1.635797,"marketCap":123549879},{"date":"2024-05-17","current":-1.021901,"twenty":-9.438101,"median":-3.244175,"eighty":-1.616702,"marketCap":122867283},{"date":"2024-05-24","current":-0.914034,"twenty":-9.420553,"median":-3.234307,"eighty":-1.583604,"marketCap":109897959},{"date":"2024-05-31","current":-0.760749,"twenty":-9.41138,"median":-3.212201,"eighty":-1.512039,"marketCap":91467866},{"date":"2024-06-07","current":-0.71817,"twenty":-9.399921,"median":-3.19964,"eighty":-1.445197,"marketCap":86348396},{"date":"2024-06-14","current":-0.681268,"twenty":-9.394014,"median":-3.183226,"eighty":-1.414673,"marketCap":81911522},{"date":"2024-06-21","current":-0.681268,"twenty":-9.364985,"median":-3.165075,"eighty":-1.408374,"marketCap":81911522},{"date":"2024-06-28","current":-0.647204,"twenty":-9.33527,"median":-3.154923,"eighty":-1.406658,"marketCap":77815946},{"date":"2024-07-05","current":-0.522305,"twenty":-9.245436,"median":-3.134988,"eighty":-1.391193,"marketCap":62798833},{"date":"2024-07-12","current":-0.556255,"twenty":-9.245436,"median":-3.12861,"eighty":-1.379453,"marketCap":66880758},{"date":"2024-07-15","current":-0.539337,"twenty":-9.24497,"median":-3.124128,"eighty":-1.375757,"marketCap":64846621},{"date":"2024-08-02","current":-0.53366,"twenty":-9.244504,"median":-3.119646,"eighty":-1.374083,"marketCap":64164025},{"date":"2024-08-09","current":-0.471778,"twenty":-9.229066,"median":-3.11611,"eighty":-1.373583,"marketCap":56723729},{"date":"2024-08-16","current":-0.518664,"twenty":-9.205509,"median":-3.086986,"eighty":-1.361947,"marketCap":61251148},{"date":"2024-08-23","current":-0.532854,"twenty":-9.186794,"median":-3.052436,"eighty":-1.350103,"marketCap":62926919},{"date":"2024-08-30","current":-0.498161,"twenty":-9.164335,"median":-3.036112,"eighty":-1.349665,"marketCap":58829830},{"date":"2024-09-06","current":-0.477831,"twenty":-9.160592,"median":-3.008996,"eighty":-1.345261,"marketCap":56429031},{"date":"2024-09-13","current":-0.608149,"twenty":-9.1294,"median":-2.985027,"eighty":-1.338161,"marketCap":71818767},{"date":"2024-09-20","current":-0.545655,"twenty":-9.054514,"median":-2.972655,"eighty":-1.330145,"marketCap":64438533},{"date":"2024-09-27","current":-0.425704,"twenty":-8.99455,"median":-2.939173,"eighty":-1.310084,"marketCap":50273137},{"date":"2024-10-04","current":-0.382844,"twenty":-8.906062,"median":-2.90187,"eighty":-1.298447,"marketCap":45211623},{"date":"2024-10-11","current":-0.379195,"twenty":-8.867383,"median":-2.866237,"eighty":-1.286707,"marketCap":44780711},{"date":"2024-10-18","current":-0.415221,"twenty":-8.846173,"median":-2.798221,"eighty":-1.278435,"marketCap":49035118},{"date":"2024-10-25","current":-0.404448,"twenty":-8.816228,"median":-2.741001,"eighty":-1.266894,"marketCap":47762900},{"date":"2024-10-31","current":-0.462425,"twenty":-8.796265,"median":-2.678254,"eighty":-1.256183,"marketCap":54609622},{"date":"2024-11-08","current":-0.483102,"twenty":-8.777549,"median":-2.605869,"eighty":-1.244443,"marketCap":57051460},{"date":"2024-11-15","current":-0.545729,"twenty":-8.752595,"median":-2.562438,"eighty":-1.215093,"marketCap":61374266},{"date":"2024-11-22","current":-0.486125,"twenty":-8.702687,"median":-2.537095,"eighty":-1.209633,"marketCap":54671062},{"date":"2024-11-29","current":-0.508108,"twenty":-8.642798,"median":-2.526206,"eighty":-1.207642,"marketCap":57143312},{"date":"2024-12-06","current":-0.515985,"twenty":-8.604244,"median":-2.509356,"eighty":-1.179879,"marketCap":58029202},{"date":"2024-12-13","current":-0.59726,"twenty":-8.596976,"median":-2.494879,"eighty":-1.174002,"marketCap":67169659},{"date":"2024-12-20","current":-0.541448,"twenty":-8.561698,"median":-2.48391,"eighty":-1.165115,"marketCap":60892891},{"date":"2024-12-27","current":-0.51171,"twenty":-8.508047,"median":-2.473163,"eighty":-1.157611,"marketCap":57548486},{"date":"2025-01-03","current":-0.683909,"twenty":-8.475606,"median":-2.463131,"eighty":-1.136239,"marketCap":76914445},{"date":"2025-01-10","current":-1.80511,"twenty":-8.449405,"median":-2.455961,"eighty":-1.132912,"marketCap":203008141},{"date":"2025-01-17","current":-1.506104,"twenty":-8.343351,"median":-2.43697,"eighty":-1.133052,"marketCap":169381025},{"date":"2025-01-24","current":-1.694368,"twenty":-8.27847,"median":-2.423838,"eighty":-1.133611,"marketCap":190553654},{"date":"2025-01-31","current":-1.539327,"twenty":-8.265993,"median":-2.417012,"eighty":-1.14018,"marketCap":173117372},{"date":"2025-02-07","current":-1.661145,"twenty":-8.234801,"median":-2.412842,"eighty":-1.147587,"marketCap":186817308},{"date":"2025-02-14","current":-1.472882,"twenty":-8.178655,"median":-2.401301,"eighty":-1.156392,"marketCap":165644679},{"date":"2025-02-21","current":-1.550402,"twenty":-8.14871,"median":-2.396615,"eighty":-1.158018,"marketCap":174362820},{"date":"2025-02-28","current":-1.229247,"twenty":-8.091316,"median":-2.390177,"eighty":-1.161494,"marketCap":138244807},{"date":"2025-03-07","current":-1.092885,"twenty":-7.932096,"median":-2.375176,"eighty":-1.146106,"marketCap":122909073},{"date":"2025-03-14","current":-0.907261,"twenty":-7.863918,"median":-2.354934,"eighty":-1.131738,"marketCap":102033247},{"date":"2025-03-21","current":-0.945317,"twenty":-7.734578,"median":-2.331595,"eighty":-1.115782,"marketCap":106313228},{"date":"2025-03-28","current":-0.817792,"twenty":-7.650225,"median":-2.324564,"eighty":-1.09831,"marketCap":95611314},{"date":"2025-04-04","current":-0.630056,"twenty":-7.63607,"median":-2.316328,"eighty":-1.087663,"marketCap":73662412},{"date":"2025-04-11","current":-0.665831,"twenty":-7.582578,"median":-2.310505,"eighty":-1.078211,"marketCap":77844939},{"date":"2025-04-17","current":-0.69413,"twenty":-7.542253,"median":-2.301851,"eighty":-1.062489,"marketCap":81153505},{"date":"2025-04-25","current":-0.776678,"twenty":-7.514136,"median":-2.292752,"eighty":-1.053387,"marketCap":90804530},{"date":"2025-05-02","current":-0.705877,"twenty":-7.50064,"median":-2.287071,"eighty":-1.041502,"marketCap":82526872},{"date":"2025-05-09","current":-0.170863,"twenty":-7.438781,"median":-2.261574,"eighty":-1.033122,"marketCap":19976247},{"date":"2025-05-16","current":-0.179914,"twenty":-7.380296,"median":-2.254265,"eighty":-1.026318,"marketCap":21337129},{"date":"2025-05-23","current":-0.196653,"twenty":-7.322936,"median":-2.231804,"eighty":-1.016643,"marketCap":23322268},{"date":"2025-05-30","current":-0.205391,"twenty":-7.266701,"median":-2.212953,"eighty":-1.007063,"marketCap":24358536},{"date":"2025-06-06","current":-0.235598,"twenty":-7.176725,"median":-2.198026,"eighty":-0.996722,"marketCap":27940948},{"date":"2025-06-13","current":-0.218107,"twenty":-7.091248,"median":-2.186035,"eighty":-0.9897,"marketCap":25866620},{"date":"2025-06-20","current":-0.225483,"twenty":-7.06313,"median":-2.177232,"eighty":-0.984888,"marketCap":26741337},{"date":"2025-06-27","current":-0.937755,"twenty":-7.017017,"median":-2.160533,"eighty":-0.976485,"marketCap":111213972},{"date":"2025-07-03","current":-2.012485,"twenty":-7.012519,"median":-2.155846,"eighty":-0.976495,"marketCap":238672683},{"date":"2025-07-11","current":-2.433948,"twenty":-6.995648,"median":-2.158189,"eighty":-0.978124,"marketCap":288656491},{"date":"2025-07-18","current":-2.507704,"twenty":-6.939413,"median":-2.170499,"eighty":-0.983912,"marketCap":297403657},{"date":"2025-07-25","current":-2.286436,"twenty":-6.877554,"median":-2.177232,"eighty":-0.984151,"marketCap":271162158},{"date":"2025-08-01","current":-2.18107,"twenty":-6.877554,"median":-2.186035,"eighty":-0.987838,"marketCap":258666206},{"date":"2025-08-08","current":-2.210351,"twenty":-6.871931,"median":-2.194443,"eighty":-0.987838,"marketCap":262138745},{"date":"2025-08-15","current":-0.150702,"twenty":-6.826943,"median":-2.186035,"eighty":-0.984151,"marketCap":250832559},{"date":"2025-08-22","current":-0.165163,"twenty":-6.821319,"median":-2.182518,"eighty":-0.976483,"marketCap":274902350},{"date":"2025-08-29","current":-0.152986,"twenty":-6.776331,"median":-2.166732,"eighty":-0.967508,"marketCap":254633053},{"date":"2025-09-05","current":-0.146897,"twenty":-6.753837,"median":-2.159997,"eighty":-0.952083,"marketCap":244498404},{"date":"2025-09-12","current":-0.138144,"twenty":-6.698727,"median":-2.155846,"eighty":-0.934861,"marketCap":229929846},{"date":"2025-09-19","current":-0.12495,"twenty":-6.632369,"median":-2.132413,"eighty":-0.906774,"marketCap":207970473},{"date":"2025-09-26","current":-0.138966,"twenty":-6.551391,"median":-2.12408,"eighty":-0.849368,"marketCap":231298740},{"date":"2025-10-03","current":-0.150762,"twenty":-6.53452,"median":-2.118475,"eighty":-0.805631,"marketCap":250932795},{"date":"2025-10-10","current":-0.130619,"twenty":-6.49853,"median":-2.114896,"eighty":-0.774158,"marketCap":217405930},{"date":"2025-10-17","current":-0.119666,"twenty":-6.480534,"median":-2.089521,"eighty":-0.758531,"marketCap":199174537},{"date":"2025-10-24","current":-0.114312,"twenty":-6.397307,"median":-2.069006,"eighty":-0.747034,"marketCap":190264458},{"date":"2025-10-29","current":-0.110874,"twenty":-6.372563,"median":-2.0668,"eighty":-0.740311,"marketCap":184541445}],"updateTime":1761848411157},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VOR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579181478","title":"Vor Biopharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2579181478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579181478?lang=en_us&edition=fundamental","pubTime":"2025-10-30 01:46","pubTimestamp":1761759960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2025 13:46 ET (17:46 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2579839171","title":"BRIEF-Vor Biopharma Says 100% Patients On Telitacicept Achieve ≥2-Point MG-ADL Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2579839171","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579839171?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:44","pubTimestamp":1761752643,"startTime":"0","endTime":"0","summary":"BRIEF-Vor Biopharma Says 100% Patients On Telitacicept Achieve ≥2-Point MG-ADL ImprovementOct 29 (Reuters) - Vor Biopharma Inc VOR.O:TELITACICEPT DEMONSTRATES SUSTAINED EFFICACY AND FAVORABLE SAFETY P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA1R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2579188904","title":"Vor Bio says telitacicept shows sustained efficacy in China Phase 3 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2579188904","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579188904?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:05","pubTimestamp":1761750345,"startTime":"0","endTime":"0","summary":"Vor Bio (VOR) announced that its collaborator, RemeGen Co., presented 48-week open-label extension data from its Phase 3 study in China evaluating ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vor-bio-says-telitacicept-shows-sustained-efficacy-in-china-phase-3-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vor-bio-says-telitacicept-shows-sustained-efficacy-in-china-phase-3-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2579900040","title":"Vor Biopharma Reports Telitacicept Achieves Sustained Efficacy in Phase 3 Myasthenia Gravis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2579900040","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579900040?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:01","pubTimestamp":1761750075,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc. has announced new 48-week open-label extension data from a Phase 3 clinical study in China evaluating telitacicept for patients with generalized myasthenia gravis . The results, presented at the American Association of Neuromuscular & Electrodiagnostic Medicine  Annual Meeting on October 29, 2025, indicate that telitacicept demonstrated sustained efficacy and a favorable safety profile. In the study, 100% of patients treated with telitacicept for 48 weeks achieved a ≥2-point improvement in Myasthenia Gravis Activities of Daily Living , with a mean reduction of 7.5 points. The global Phase 3 trial of telitacicept is currently enrolling participants across 14 countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL4YVlk3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","LU2210150020.SGD","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2095319765.USD","BK4139","VOR","IE00B64PRP62.GBP","BK4588","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2579900053","title":"Vor Biopharma Inc - 100% Patients on Telitacicept Achieve ≥2-Point Mg-Adl Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2579900053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579900053?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:01","pubTimestamp":1761750065,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA1R2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2579900037","title":"Vor Biopharma Inc - Telitacicept Shows Favorable Profile Compared to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2579900037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579900037?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:01","pubTimestamp":1761750065,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA1R2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2579000559","title":"Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2579000559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579000559?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:01","pubTimestamp":1761750065,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA1R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2579000309","title":"Vor Biopharma Inc - No Injection Site Reactions in Telitacicept Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2579000309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579000309?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:01","pubTimestamp":1761750065,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA1R2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2579069529","title":"Corrected-Vor Biopharma Inc. : H.c. Wainwright Raises Target Price to $55(Not $52) From $3 to Reflect 1-for-20 Reverse Stock Split  (Clarifies PT Is Split-Adjusted)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579069529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579069529?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:53","pubTimestamp":1761742429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4N3WA1LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2579907119","title":"Vor Biopharma Unveils Promising Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579907119","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579907119?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:09","pubTimestamp":1761685773,"startTime":"0","endTime":"0","summary":"Vor Biopharma ( ($VOR) ) has provided an update. On October 28, 2025, Vor Biopharma Inc. hosted a webcast to present 48-week Phase 3 clinical trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vor-biopharma-unveils-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vor-biopharma-unveils-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2578608644","title":"Peter Kolchinsky, Director, Reports Disposal of Vor Biopharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2578608644","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578608644?lang=en_us&edition=fundamental","pubTime":"2025-10-28 08:04","pubTimestamp":1761609885,"startTime":"0","endTime":"0","summary":"RA Capital Management, L.P. has reported a disposal of common shares of Vor Biopharma Inc. . Other reporting beneficial owners include RA Capital Healthcare Fund LP, Peter Kolchinsky, and Rajeev M. Shah. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL6ZqyYW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2578503599","title":"Major Moves: Fifth Third, HEICO, Transdigm, Cytokinetics, Vor Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2578503599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578503599?lang=en_us&edition=fundamental","pubTime":"2025-10-25 21:01","pubTimestamp":1761397291,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($FITB)), (($HEI)), (($TDG)), (($CYTK)) and (($VOR)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/major-moves-fifth-third-heico-transdigm-cytokinetics-vor-biopharma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/major-moves-fifth-third-heico-transdigm-cytokinetics-vor-biopharma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4505","BK4550","BK4139","LU0198837287.USD","BK4187","BK4588","CYTK","VOR","TDG"],"gpt_icon":0},{"id":"2577034587","title":"RA Capital Management Reports Disposal of Vor Biopharma Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2577034587","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577034587?lang=en_us&edition=fundamental","pubTime":"2025-10-23 07:48","pubTimestamp":1761176923,"startTime":"0","endTime":"0","summary":"RA Capital Management, L.P. reported a disposal of common shares of Vor Biopharma Inc. The filing was submitted by multiple reporting owners, including RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL1Sv80D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2577621380","title":"Major Shareholder Offloads Thousands of Vor Biopharma Shares!","url":"https://stock-news.laohu8.com/highlight/detail?id=2577621380","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577621380?lang=en_us&edition=fundamental","pubTime":"2025-10-22 10:03","pubTimestamp":1761098597,"startTime":"0","endTime":"0","summary":"New insider activity at Vor Biopharma ( ($VOR) ) has taken place on October 21, 2025. Significant shareholder Reprogrammed Interchange LLC has rece...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-shareholder-offloads-thousands-of-vor-biopharma-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-shareholder-offloads-thousands-of-vor-biopharma-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2577388641","title":"Reprogrammed Interchange LLC Reports Disposal of Vor Biopharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2577388641","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577388641?lang=en_us&edition=fundamental","pubTime":"2025-10-22 05:45","pubTimestamp":1761083138,"startTime":"0","endTime":"0","summary":"Reprogrammed Interchange LLC has reported a disposal of common shares of Vor Biopharma Inc., according to a recent SEC filing. Some of the reporting owners include Reprogrammed Interchange LLC and Reid Hoffman, among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL3cDPCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2576209958","title":"Major Vor Biopharma Stock Sales by Key Shareholders!","url":"https://stock-news.laohu8.com/highlight/detail?id=2576209958","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576209958?lang=en_us&edition=fundamental","pubTime":"2025-10-18 10:03","pubTimestamp":1760753036,"startTime":"0","endTime":"0","summary":"New insider activity at Vor Biopharma ( ($VOR) ) has taken place on October 17, 2025. Significant shareholder Reprogrammed Interchange LLC recently...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-vor-biopharma-stock-sales-by-key-shareholders-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-vor-biopharma-stock-sales-by-key-shareholders-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2576062740","title":"RA Capital Management Reports Sale of Vor Biopharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576062740","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576062740?lang=en_us&edition=fundamental","pubTime":"2025-10-18 06:03","pubTimestamp":1760738633,"startTime":"0","endTime":"0","summary":"RA Capital Management, L.P. reported a disposal of common shares of Vor Biopharma Inc. , according to a recent SEC Form 4 filing. The filing was submitted by more than one reporting person, including RA Capital Management, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL8PZ9n1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2576032221","title":"Vor Biopharma Announces Positive Phase 3 Results for Telitacicept in IgA Nephropathy; Data to Be Presented at ASN Kidney Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576032221","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576032221?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:00","pubTimestamp":1760702410,"startTime":"0","endTime":"0","summary":"Vor Biopharma Announces Positive Phase 3 Results for Telitacicept in IgA Nephropathy; Data to Be Presented at ASN Kidney Week 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on October 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL6QGQRz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU2210149790.SGD","BK4588","VOR","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","BK4139","NDAQ","BK4585","LU2210150020.SGD","LU2148510915.USD","IE00B3QW5Z07.USD","LU1064130708.USD","688331","LU2095319765.USD","BK0239","LU1064131003.USD","IE00BKPKM429.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2576103277","title":"Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 Iga Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576103277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576103277?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:00","pubTimestamp":1760702401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nTUAPTWX2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2575583745","title":"Vor Biopharma Announces Positive Phase 3 Trial Results for Telitacicept in Lupus, Published in NEJM","url":"https://stock-news.laohu8.com/highlight/detail?id=2575583745","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575583745?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:00","pubTimestamp":1760616045,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc. has announced the publication of results from a Phase 3 clinical study evaluating telitacicept in patients with systemic lupus erythematosus  in The New England Journal of Medicine. The study, conducted at 42 hospitals in China and sponsored by RemeGen Co., Ltd., included 335 patients with active SLE despite standard therapy. Telitacicept demonstrated a statistically significant improvement in disease activity, with 67.1% of patients achieving a modified SLE Responder Index-4  response at week 52, compared to 32.7% in the placebo group . Additional secondary measures, such as SELENA-SLEDAI score reduction, also favored telitacicept. The results have already been presented through publication in a peer-reviewed journal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inter","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL16jxJz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","LU2148510915.USD","VOR","IE00BKPKM429.USD","688331","LU1064131003.USD","BK4588","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","LU2210150020.SGD","BK4585","BK0239","BK4112","LU1064130708.USD","BK4139","LU2488822045.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":108,"code":"91000000","status":"200"}]}}